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Executive Summary 
As a part of the Masters of Science in Behavioral Health field placement, an 
evaluation was conducted of the integrated treatment plan in mental health and 
substance abuse at Bay Area Addiction Research and Treatment (BAART) programs.  
The goal of the BAART programs are to provide comprehensive mental health and 
substance abuse outpatient recovery services, as well as on-site primary health care 
services for substance users, mainly opioid use. There is a link between increased 
substance abuse and increased rates of depression and anxiety. These disorders use 
the same neuro chemical pathway and are highly codependent upon one another. 
Because of this there is a need to treat both the mental health and substance abuse 
problem in parallel for best results.  
The researcher examined the interaction of the substance abuse problem and 
mental health concerns to evaluate the effectiveness of treatment in the areas 
concerning anxiety, depression, and substance use. The evaluation revealed that 
there was not a statistically significant decrease in any of the variables. Based upon 
the results, recommendations were made to improve patient treatment. The 
recommendations consisted of using motivational interviewing to assess what part 
of the change process the client was in in order to provide the best recommendation 
for potential treatment options. This included adding medication therapy for low 
functioning clients with severe symptoms of anxiety or depression to improve 
overall outcomes. The paper also looked into more holistic treatments for clients 
who are more fragile with less severe psychiatric symptoms and would prefer to 
eliminate any risk of relapse.  The goal of the evaluation is to help BAART provide 
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more patient centered care to each of their clients that will lead to long lasting 
change. The study will aid in the improvement of the overall integrated program at 
BAART Programs in San Francisco’s Tenderloin District.   
Agency background 
Traditionally, harm reduction has focused exclusively on the substance abuse 
disorders and the mental health component has been treated separately. In San 
Francisco’s Department of Public Health, the Community Substance Abuse service 
provided drug treatment and the Community Mental Health Services carried out 
mental health treatment. Data analysis revealed that many of the same patients 
were utilizing both services. Consequently, San Francisco combined the services 
from both departments to create the Community Behavioral Health Services (CBHS). 
CBHS integrates care for individuals with comorbidities, dealing with substance 
abuse addiction and mental health concerns.  Integrated treatment utilizes a harm 
reduction model to coordinate care so that the same team of clinicians can address 
mental health and substance abuse issues at the same time.  Thus, treatment 
directly impacts the interaction of the substance abuse and mental health issues. 
Integrated care facilitates an understanding of the interaction between the two 
disorders, the treatment is more collaborative, and leads to better patient outcome.  
Bay Area Addiction Research and treatment (BAART) utilizes this integrated 
care model in a medication assistance withdrawal program for opiate addiction in 
San Francisco’s Tenderloin District.  BAART began offering mental health services to 
its patients who suffer from substance abuse addiction. The company now offers 
psychiatric services, medication evaluation, medication management, individual and 
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group therapy, and crisis intervention. They are committed to providing services 
over a long period of time. They do not impose artificial time constraints – this is 
based on the knowledge that mental illnesses are long term or a lifetime.  BAART 
measures success of the treatment based upon how long the individual stays on 
methadone.  
Mental health services will be provided through group or individual therapy 
along with pharmacological therapies. These interventions are designed to provide 
a reduction in mental disability and improvement in function in matters of 
independent living and enhanced self-sufficiency.  These goals will be accomplished 
through providing assessment that will include a clinical analysis of patient history 
and current mental health status. The assessment will also provide cultural 
implications, testing procedures and a diagnosis. BCH will also provide group and 
individual therapy that will mostly focus on reducing the symptoms as a means of 
improving functional impairments. Therapy will also incorporate any other 
individual that is important to the client's treatment plan such as family so they can 
serve as a support system for the client’ long-term success.  
Bay Area Addiction Research and treatment (BAART) utilizes this integrated 
care model in a medication assistance withdrawal program for opiate addiction in 
San Francisco’s Tenderloin District.  BAART began offering mental health services to 
its patients who suffer from substance abuse addiction. The company now offers 
psychiatric services, medication evaluation, medication management, individual and 
group therapy, and crisis intervention. They are committed to providing services 
over a long period of time. They do not impose artificial time constraints – this is 
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based on the knowledge that mental illnesses are long term.  BAART measures 
success of the treatment based upon how long the individual stays on methadone.  
Mental health services will be provided through group or individual therapy 
along with pharmacological therapies. These interventions are designed to provide 
a reduction in mental disability and improvement in function in matters of 
independent living and enhanced self-sufficiency.  These goals will be accomplished 
through providing assessment that will include a clinical analysis of patient history 
and current mental health status. The assessment will also provide cultural 
implications, testing procedure and a diagnosis. BCH will also provide group and 
individual therapy that will mostly focus on reducing the symptoms as a means of 
improving functional impairments. Therapy will also incorporate any other 
individual that is important to the client's treatment plan such as family so they can 
serve as a support system for the client’ long-term success. BAART’s mission is to 
provide people with cost-effective, comprehensive substance abuse treatment and 
other health care services at its clinics or through community linkages, and to make 
such services available to as many people as possible who seek them.  
With prescription drug use on the rise, medication-assisted withdrawal such 
as methadone maintenance is a popular approach to treat opioid- addiction. 
However, the number of individuals in California receiving treatment in narcotics 
treatment programs has been declining steadily (Urada et al., 2011).  In 1997, the 
National Consensus Development Panel of Effective Medical Treatment of Opioid 
Addiction stated that narcotics replacement treatment is the most effective way of 
treating opioid dependence (NIH, 1997).  With such support methadone has become 
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the oldest, most widely used, and most regulated medication prescribed for opioid 
addiction. Through measuring self- reports, narcotics replacement therapy was 
concluded as being more effective than non- pharmacological approaches in 
retaining patients and suppressing heroin use.  It has shown to have a high retention 
rate, and is associated with fewer relapses (Jones et al., 2012).  Narcotics therapy 
poised with harm reduction programming is another particularly promising 
approach that is typically attended by high-risk underserved populations and their 
support networks.  Key components of a harm reduction program focus on 
improving nutrition, decreasing smoking, decreasing alcohol and drug use, 
encouraging physical activity, and securing social and community support. 
Furthermore, it has been shown to prevent drug related disabilities (Jones et al., 
2012). 
Needs Assessment/Problem Statement  
A large part of BAART clients are prescription drug users, whose numbers 
have been on the rise.  There is a tremendous rise in legal prescription drug use, 
which has also brought about illegal prescription drug use especially opioid drug 
use.  In 2010, 2 million people used prescription painkillers for non-medical reasons 
for the first time within the last year (SAMHSA, 2010). Prescription painkillers bind 
to the pain receptors in the brain and provide a euphoric effect that can also cause a 
decrease in breathing rates with continuous use; ever-increasing amounts of the 
drug are needed to achieve the same euphoric feelings. Three out of four 
prescription drug overdoses are due to opioid prescription. In 2008, there were 
14,800 cases of prescription opioids overdoses, more than cocaine and heroin 
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combined (CDC, 2008).   Misuse of these prescription painkillers was the cause of 
475,000 ER cases in 2009, which has doubled in about five years (SAMHSA, 2010). 
Over the last decade sales of prescription opioids in the US have tripled Guglemann, 
H.& Nelson, L., 2012).  In 2010, 33 million people reported using prescription 
opioids like hydrocodone, the most commonly prescribed form of prescription 
opioid for non-medical use. For example, hydrocodone/acetaminophen is 
prescribed 100 million times more than any other medications (Back, Payne, 
Simpson, Brady, 2010).  
It was also discovered by Goldner E.M., Lusted A., Roerecke M., Rehm J., 
Fischer B. (2013) that individuals who are non-medical prescription opioid users 
and those with mental health problems share the presence of chronic pain. Pain 
control is one of the primary reasons individuals begin to have problems with 
excessive and misuse of opioids. Along with that persistent pain is also a key factor 
in the development of depressive symptoms and other mental health problems 
(Goldner et al., 2013).  This can lead to more intense pain symptoms through 
neuromechanical factors that then create a positive feedback loop, which leads 
down the road of addiction.  
One of the reasons for the drastic rise in prescription drug use is the ease of 
access in obtaining the drug. In her study, Hamilton (2012) points out that the 
majority of individuals who reported using drugs for non-medical purposes (55.3%) 
reported they acquired the drug at no cost from a friend or relative who had 
obtained the drug from a doctor. A smaller percentage (17.6%) reported they had 
obtained the opioid from a doctor's prescription. A relatively small percentage 
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(4.8%) reported purchasing their prescription opioids from a dealer, and a 
relatively small number of people (0.4%) reported purchasing opioids online 
(Hamilton, 2012).  Prescription drugs are easily accessible and have fewer stigmas 
associated with them because a medical professional often prescribes them.   
Psychological disorders such as anxiety and depression are very common for 
those with pain and addiction both have implications in opiate abuse (Manchikanti, 
Giordano, Boswell, Fellows, Manchukonda, and Pampati, 2007).  Studies examining 
the link between non-medical prescription opioid use and mental health 
comorbidities found a high association between the two phenomena (Amari, Rehm, 
Goldner& Fisher, 2011).  A systematic review found that there is a 43% prevalence 
of individuals with co-occurring mental health disorders in the substance abuse 
population. This rate is three to four times higher than the rate of psychiatric 
disorders among the normal population, which ranges from 10-17%. The rate of 
depression among substance abuse users is approximately 27%, while the rate of 
depression among the normal population ranges from 2-5% (Manchikanti et.al, 
2007).  Depression among substance users has been associated with poorer 
treatment outcomes, increased risk of suicide, and a worse prognosis.  Along with 
that the rate of anxiety among drug users is 29% while among the normal 
population it averages about 6-10% (Manchikanti et. al., 2007). Not only are rates 
for psychiatric illness higher in the substance abuse population when compared to 
the normal population; these rates are even higher for substance users in drug 
treatment programs, by a third or more, compared to substance users not in 
treatment.  Higher levels of comorbidities among the treatment population could be 
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linked to more severe disease symptoms and/or problems, thus they are more likely 
to end up in treatment. While the rate of psychiatric disorders varies among 
different studies depending on the study design and it tends to be more prevalent in 
the substance use populations.   
Psychological distress can lead someone to abuse prescription drugs and 
often result in someone using multiple agents to escape their distress (Matteliano, 
2014). There are three explanatory models, which discuss the link between non-
medical prescription opioid use and psychiatric disorders. The first of these is the 
self-medication model which states that individuals self-medicate to relive 
psychiatric symptoms or control distressing emotions through drug use.  Next, the 
prescription model theorizes that substance abuse may induce psychiatric 
symptoms as they interact with similar parts of brain functioning and may modify 
neurotransmitter functioning. This could also be induced through neural plasticity, 
activation of dormant genes, or through psychosocial factors. Lastly the shared 
liability model proposes that psychiatric disorders and substance abuse operate 
though similar mechanism including genetics, neurobiological, and psychosocial 
pathways.  None of these models are considered to be mutually exclusive and may 
operate synergistically.  For example, someone who is self- medicating may be more 
vulnerable to addiction due to genetics and thus both can lead to the individual 
developing an issue with substance abuse and a psychiatric disorder (Goldner et al., 
2013).  
Nicolson et. al., (2009) stated that patients with depression are more likely to 
report pain than those without depression. They are also more likely to report more 
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intense pain for a physical problem, to have unexplained pain, and worse outcomes 
despite treatment. For patients with comorbid pain and depression, worsening pain 
tends to increase depressive symptoms and vice versa (Nicolson et al., 2009).  This 
may result because depression and pain are neutrally linked though brain 
structures that are involved with emotions such as the amygdala and the 
hypothalamus. Pain and depression also share neurological pathways that use 
serotonin and norepinephrine in depression and modulating pain signals. Much like 
depression anxiety is closely linked to pain Nicolson et al., (2009) also reported that 
patients experiencing anxiety and pain such as headaches, and have headaches that 
are tougher to treat. They address that anxiety and pain are interlinked and both 
much be treated in parallel to obtain optimal results.   
By June 1st recommendations based on the results from an evaluation 
followed by a literature review of best practices will be made for BAART programs 
in the Tenderloin District of San Francisco to improve services.  Some of the 
potential obstacles include not having enough funding to hire a new psychiatrist on 
staff. Another barrier is offering patients anxiety medication. This is because when 
anxiety medication is given with methadone it tends to produce a euphoric effect 
similar to that of opioid use.  As of right now, the patients with anxiety are given 
Selective Serotonin Reuptake Inhibitors (SSRI’s) because they are a safer option and 
there is little risk for overdose.  While medication maintenance is one of the most 
reliable forms of therapy, since many of the patients are homeless or transient they 
may be less medication compliant, which could affect treatment goals and outcomes. 
However because the services the patients are utilizing daily are in house they are 
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able to take their psych meds at the same time as their methadone thereby reducing 
the chances of patients not being medication compliant. While it is fairly easy to 
determine whether medication is distributed to the patients it is tougher to know if 
counselors and therapists will follow the recommendations as each has a different 
style of therapy. Many of the clients are assigned student interns who rotate yearly 
making it difficult to provide continuous quality care to clients. All of these factors 
could possibly hinder quality care to clients if they are not addressed in a timely and 
appropriate manner.  
Target Population  
BAART has 22 clinics throughout the state, however, this paper’s target 
population is homeless or marginally housed residents in the San Francisco's 
Tenderloin, Market Street, and neighboring downtown areas. These residents are 
culturally and ethnically diverse and include approximately 50% Caucasian, 25% 
African American, 9% Latino, 2% Southeast Asian and others minority populations 
(BAART Community Healthcare, 2011). Behavioral Community Health Services aims 
to provide culturally competent and linguistically appropriate services to their 
clients.  Approximately 58% of the population is male and 42% is female. Of the 
target population about 15% of them identify as Lesbian, Gay, Bi Sexual, 
Transgender, Queer, and Questioning (LGBTQQ). The majority of the population is 
between the aged of 25-60 with approximately 10% of the target population is 18-
25 and another 10% is 61 and over (BAART Community Healthcare, 2011). BCH 
operates a program where recently released inmates are referred directly to 
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BCH/BAART. BCH will also reach out to incarcerated individuals being released 
from the San Francisco County Jails to provide jail based aftercare services.  
Goals and Objectives 
Goal: To reduce the number of individuals reporting symptoms of depression and 
Anxiety 
Objectives: 
• Increase the number of patients who are compliant with their psychiatric 
medication from 20% to 50% through follow-up phone calls and reminders 
by June, 2015.  
• Increase staff training from once a month to twice a month to identify 
individuals who are good candidates for psychiatric medication by 
September 2014.  
• Establish a follow up protocol for patients who are coming out of the hospital 
and identify the reason for their visit and future precautions to avoid re-
admittance by September 2014 to decrease hospital visits from 2% to .05%.  
Goal: Reduce the number of positive urinary drug screens for all drugs 
Objectives 
• Train counselors to practice motivational interviewing skills in order to 
provide more client centered treatment to decrease drug use from 3.2 
positive urinary drug screens to 2.8 by June 2015.  
• Train counselors to have a harm reduction viewpoint vs. an abstinence 
viewpoint towards drug use in order to increase retention and decrease drug 
use from 3.2 to 2.8 by June 2015.   
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Program Evaluation 
The program was established in 2010 and the author is conducting an 
evaluation of the integrated mental health program to see how successful the 
program has been in meeting its goals and objectives.   The study will aid in the 
improvement of the overall integrated program at BAART Programs in San 
Francisco.  For this study/evaluation the participants included 61 Methadone 
Maintenance Treatment (MMT) patients enrolled in the integrated mental health 
and MMT program at BAART Programs at the Turk and Market Street Clinics. The 
current analysis includes patients who have been enrolled in MMT for at least one 
year and who had been in the mental health program for at least six months.  The 
evaluation will be done through a retrospective chart review to collect information 
on four clinical outcomes including Urinary Drug Screens (UDS), feelings of 
depression and anxiety. 
 Urine drug screen data was extracted from the patient’s electronic medical 
records for a period of six months before and six months after their admittance into 
the mental health program. Patients give a random drug sample each month and 
positive UDS are recorded into the database, this includes various opioids and non-
opioids on a 9-line item scale. These measures already existed in BAART’s database 
and is a critical part of their treatment and assessment process. To measure the 
rates of depression and anxiety among the BAART population, the Addiction 
Severity Index (ASI) was used. The ASI is a self reported assessment that is 
conducted annually with the client and their counselor. The following two questions 
were used in the analysis (‘Experiences serious depression- sadness hopelessness, 
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loss of interest, difficulty with daily function? ’and ‘Experienced serious 
anxiety/tension, uptight, unreasonably worried, inability to feel relaxed?’).  Items 
are rated on a four-point scale (0 - Not at all; 1 – Slightly; 2 – Moderately; 3 – 
Considerably; 4 – Extremely). Client’s answers to these questions pre and post 
entrance into the mental health program were averaged and used in analysis of the 
effectiveness of the integrated treatment services.  
UDS data is extracted from the patient’s electronic medical record; the 
average positive number of urinary drug screens before starting the mental health 
program is 3.49 and six months after the individual has been enrolled the number 
has gone down to 3.2. While the graph represents a longitude and a cross sectional 
review one can clearly see that there is no noticeable pattern of deceased drug use 
among the clients. This graph showed that there was not a significant change in the 
decrease of urinary drug screens before and after entrance into the mental health 
program at BAART. The second graph attempts to analyze just the use of opioids six 
months pre and most entrance into the mental health program. Going into the 
evaluation it was believed that this graph would show a more significant decline 
since methadone is primarily used to treat opioid addiction.  However, as one can 
tell from the second graph no significant patter can be seen to conclude that the 
treatment had any effect on the use of opioids throughout the twelve- month 
observation period.  
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To measure the rates of depression and anxiety among the BAART 
population, the Addiction Severity Index (ASI) was used.  The ASI is a self
assessment that is conducted annually with the client and their counselor. There are 
14 items in this scale and the following 2 items in the analysis (Experienced serious 
 16
-reported 
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depression-sadness, hopelessness, loss of interest, difficulty with daily functions?) 
to which 33 (54%) patients responded “yes” and 22 (36%) of the patients 
responded “no” before entrance into the integrated mental health program.  After 
being in the mental health program for a period of six months “29” (47.5%) 
participants reported “yes” to experiencing depression while 23 (37.7%) said “no” 
they did not experience symptoms of depression.  To summarize the percentage of 
client who reported experiencing symptoms of depression went from 54% to 
47.5%. A Chi Square analysis revealed that there was not a significant decrease in 
the pre and post assessment responses.  
In the same survey patients were asked if they experienced symptoms of 
anxiety (Experienced serious anxiety/tension, uptight, unreasonably worried?). Out 
of 37 participants reported “yes” too experiencing symptoms of anxiety while 18 
program participants said “no” to having symptoms of anxiety. Six months after 
their entrance into the integrated mental health program at BAART 31 clients said 
“yes” to having anxiety concerns while 21 reported “no” to experiencing any 
problems with anxiety. Another Chi Square analysis revealed that these results were 
not statically significant in reduction of symptoms of anxiety six months pre and 
post entrance into the mental health program. 
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Recommendations for Practice  
All Patients come with different strengths and weaknesses, which play a 
large role in the treatment and recovery process. Along with that, patients are at 
different levels of the treatment and recovery process when they come in, which can 
make it challenging for counselors and practitioners.  There is no one answer or 
solution to patient’s problems.  A good way for counselors to assess what stage of 
change a patient is in is to use motivational interviewing upon first meeting a 
patient.  
While the sample size for my evaluation was fairly small and may have 
contributed to the lack of data when assessing the significance of the results, Ling 
W., Hillhouse M., Ang A., Jenkins J. &Fahey J. (2013), reported that it is very difficult 
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to show any added benefits of behavioral treatment with maintenance treatment.  
This lack of change may have been attributed to the fact that, the clients in BAART’s 
Tenderloin clinics are significantly low functioning in that they are unable to hold 
down a regular job, pay monthly rent and have overall low levels of social 
productivity.  In their article Wusthoff and her colleagues (2014) suggest that 
cognitive-behavioral therapy treatments are effective for higher functioning 
individuals and not as effective for lower functioning adults with psychiatric and 
substance abuse problems. These findings coupled with the results of the 
evaluation, which indicate that there was not a statistically significant decrease in 
the rate of anxiety and depression among BAART’s population, call for a more 
reliable form of treatment.  
Ling et al., (2013) also cited that patient’s beliefs about what is most 
important for their recovery was a critical part of success in client’s treatment.  
While substance users are often marginalized in society and not trusted to make 
appropriate decisions. In her study 63% of patients reported more faith in 
pharmacological therapy to increase treatment satisfaction and positive outcomes 
(Ling et al., 2013).  Client’s beliefs coincide with the research from Harts I., 
Bramness J. G., Skurtveit S., (2011) article which reported that pharmacotherapy 
with buprenorphine is effective in reducing drug use and increasing retention. They 
also concluded that drug therapy for methadone maintenance patients with 
depression and anxiety is in line with recommendations for use. SSRI’s are the drug 
of choice as they have fewer side effects when compared to older antidepressants 
(Harts I., Bramness J. G., Skurtveit S., 2011). Adding pharmacological therapy with 
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methadone maintenance for some client’s treatment modalities is a viable option 
available within the context of BAART’s services as BAART has begun to offer 
primary health care services for their clients.  Many of these patients come to 
BAART on a daily basis to receive their daily dose of methadone and adding one 
additional treatment that can be taken on the spot should be fairly easy for staff and 
clients.  
However there are barriers when using medication to treat psychiatric 
symptoms in substance abusers. For example, Goldner E.M., Lusted A., Roerecke M., 
Rehm J., Fischer B. (2013), state that patients receiving concurrent psychiatric drugs 
such as antidepressants require monitoring for potential drug interactions. This is 
especially true for anti-anxiety drugs.  This leads to a greater need for a psychiatrist 
and nurse practitioner who can closely monitor for such harmful events.  An 
additional concern is that individuals who make up a significant part of BAART’s 
Tenderloin cliental are homeless and/or transient and this population has also been 
shown to be less medication compliant.  However since most of the services are in 
house, this is a one-stop shop for clients, minimizing these risks.  
 While some clients might not show up to take their medication, others might 
opt out of taking medication completely.  Some clients who are in a very fragile state 
with their substance abuse may choose to forgo medication treatment for their 
psychiatric symptoms. Some anxiety medications have been known to cause a 
euphoric effect, the same as opioid abuse, when used in conjunction with 
methadone. As such not every patient with anxiety or depressive symptoms is a 
good candidate for pharmacological therapy. It is necessary for counselors, 
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therapists, psychiatrists, and nurse practitioners to have the proper training in 
order to accurately identify patients who would be good candidates.  Along with 
training for identifying proper candidates for psychopharmacological therapy 
counselors should also receive training on various treatment modalities.  
In addition to having a harm reduction program BAART counselors can show 
clients alternative models when dealing with pain management depending on the 
best fit for the client. One of the techniques involves biofeedback has helped patients 
manage their anxiety and may also be helpful in pain management. Biofeedback 
involves tracking ones hart rate, blood pressure and other measurements for 
continuous feedback regarding ones psychological state. Through this gained 
knowledge the hope is that the patient will learn to modify that state to some degree 
(Nicolson S.E., Caplan J.P., Williams D.E., Stern T.A., 2009).  In higher functioning 
clients Nicolson and his colleagues suggest using relaxation therapy that involves 
muscle relaxation and deep breathing too offset physiological markers of pain. 
While biofeedback might be a viable option for some patients Matteliano D., Marie 
B., Oliver J., and Coggins C. (2014) think others may be better suited using a 
biopsychosocial- spiritual (BPSS) model which uses a more holistic approach to 
mitigate drug addiction. Another BPSS technique includes guided therapy where the 
patient is told to imagine a pleasant setting in great detail to help distract them from 
pain symptoms (Matteliano D et. al., 2014). 
Patients may also choose to seek alternative treatments that are not was 
widely recommended but may still help provide relief.  Physical therapy such as 
exercise and strength building may improve functions of chronic pain and mood 
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levels of anxiety (Nicolson S.E., Caplan J.P., Williams D.E., Stern T.A., 2009).  
According to Cochrane Database review aerobic exercise had a positive effect on 
pain and a small to moderate effect on depression.  Another form of therapy that has 
been used to treat pain for more than 3,000 years is Acupuncture.  Acupuncture is 
used to treat pain; it utilizes that endogenous opioid system and stimulates the 
descending serotonin and norepinephrine inhibition in peripheral pathways 
(Nicolson et. al., 2009).   These alternative treatments have not been researched as 
widely as pharmacological therapy, however they do serve to provide some relief 
for patients suffering from pain, depression, or anxiety. These treatments are also a 
great option for clients who are seeking to avoid any form of pharmacological 
treatment in an effort to prevent the possibility of relapse during and after the 
treatment process.  
When it comes to drug use, increased retention and a relaxed drug use policy 
has shown to be the most significant factor in reducing drug use among substance 
users.  Substance Abuse and Mental Health Services Administration (2005) 
concluded that subjects assigned to a strongly abstinence-oriented program were 
more likely to leave treatment than those subjects assigned to more laissez-faire 
programs such as BAART’s.  Patients attending harm-reduction types of clinics had 
significantly better in-treatment and post-treatment outcomes in decreased use of 
illicit opiates. BAART is doing everything in line with the most current research to 
maintain a high retention rate in all their clinics. Retention has also shown to 
increase when patient’s psychiatric symptoms are managed. This leads to the 
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conclusion that while drug use is effectively controlled through integrated care in a 
maintenance setting more effective control over psychiatric disorders is necessary.  
Conclusion 
While BAART has a well-rounded approach to treating mental illness and 
substance abuse there is still room for improvement.   Their techniques of 
integrating care are innovating the way treatment for substance abuse and mental 
health is administered. An analysis of the program is likely to help see where 
changes are necessary to help patients in the program receive even better 
therapeutic treatment. This evaluation will help the company be more client- 
centered and provide treatment that is better suited to each individual’s needs. 
More effective strategies of treatment can hopefully lead to long- term success.  
Future research can look at psychiatric hospitalization to assess the type and 
number of psychotic episodes these individuals are having in an effort to decrease 
visits to the emergency room for psychiatric episodes.  
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